Evidence map›Paper›PMID 24890834›Full record

ReviewCold Spring Harbor perspectives in medicine2014

Cell therapy in dermatology.

Gabriela Petrof, Alya Abdul-Wahab, John A McGrath

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Cryomicroneedles for transdermal cell delivery.Nature biomedical engineering · 2021
    Article
  7. Article
  8. Skin tissue regeneration for burn injury.Stem cell research & therapy · 2019
    Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gabriela PetrofSt. John's Institute of Dermatology, King's College London (Guy's Campus), London SE1 1UL, United Kingdom.
Alya Abdul-WahabSt. John's Institute of Dermatology, King's College London (Guy's Campus), London SE1 1UL, United Kingdom.
John A McGrathSt. John's Institute of Dermatology, King's College London (Guy's Campus), London SE1 1UL, United Kingdom.
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Harnessing the regenerative capacity of keratinocytes and fibroblasts from human skin has created new opportunities to develop cell-based therapies for patients. Cultured cells and bioengineered skin products are being used to treat patients with inherited and acquired skin disorders associated with defective skin, and further clinical trials of new products are in progress. The capacity of extracutaneous sources of cells such as bone marrow is also being investigated for its plasticity in regenerating skin, and new strategies, such as the derivation of inducible pluripotent stem cells, also hold great promise for future cell therapies in dermatology. This article reviews some of the preclinical and clinical studies and future directions relating to cell therapy in dermatology, particularly for inherited skin diseases associated with fragile skin and poor wound healing.

Indexed as

AnimalsBone Marrow TransplantationCells, CulturedCell TransplantationDermatologyFibroblastsGuided Tissue RegenerationHumansKeratinocytesMesenchymal Stem Cell TransplantationMiceSkin DiseasesSkin TransplantationTissue Engineering

Identifiers

PMID24890834
PMCPMC4031958
OpenAlexW2125297981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.